Ventix Acquisition Talks Spark Volatile Trading Action
"Yeah, so the biggest one that I'm looking at right now and after hours is Ventix. This is ticker VTYX. So shares are up nearly 60% right now. There was a Wall Street Journal report that Eli Liy is in advance talks to acquire this biotech company for more than 1 billion which is nearly double or yeah nearly double um where it was valued as of Tuesday afternoon uh which is at about 550 million. So um shares were actually halted for for volatility right after we like closed the market but they're back up. Um, this is a company that specializes in developing medication for inflammatory diseases. So, things like Crohn's and rheumatoid arthritis and it had been a little bit of a like a rumored acquisition target in the space."
— Carmen Reiniki
Ventix (VTYX) is experiencing significant after-hours volatility with shares up nearly 60% following a Wall Street Journal report that Eli Lilly is in advanced talks to acquire the biotech for over 1 billion, nearly doubling its previous valuation. The company, which specializes in treatments for inflammatory diseases, is a rumored acquisition target, adding further catalyst to its short-term trading action.
Company CommentaryBullish Medium ConvictionScore: 7.6
Company Opinion •Stock Movers • Jan 7, 2026